BCL2 and acute myeloid leukemia: According to response to treatment, our data does not confirm the negative impact of BCL-2 overexpression on CR and OS, that has been recently reported by De Haes et al. in 93 AML patients treated with standard intensive chemotherapy or HMAs [4].